CHLOE HORVATH: Open Payments
NPI 1669874103 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 31 payments from 13 companies in 2025. Trend: 2023 $233 · 2024 $805 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| PFIZER INC. | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| Actelion Pharmaceuticals US, Inc. | 3 | $74 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Wegovy, LOKELMA, VYNDAQEL, LEQVIO, NEXLETOL, CAMZYOS, OPSYNVI, LifeVest.
Industry payments across MD — which companies pay providers there.
